The 2025 Warren Alpert Foundation Prize has been awarded to three scientists whose discoveries culminated in the development ...

Yeztugo, a twice-a-year antiviral shot to prevent HIV, was approved by the Food and Drug Administration on Wednesday, marking ...

A United Nations agency has urged the pharmaceutical company Gilead Sciences to lower the price of the long acting antiviral treatment lenacapavir following the US Food and Drug Administration (FDA)’s ...

The approval could slow new infections and move the world closer to eliminating HIV. But huge obstacles remain.

The Wistar Institute has launched its HIV Cure and Viral Diseases Center with new lab space on Market Street and a plan to ...

Although HIV may affect sperm quality and male fertility by numerous mechanisms the face of HIV care has dramatically changed ...

About 21 000 HIV patients have disappeared from Mpumalanga’s treatment system, yet officials remain unclear or deny the ...

The Trump administration's plan to cut funding for HIV vaccine research comes at a time when the field is making substantial ...

The FDA approved lenacapavir (Yeztugo) as pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 in at ...

The launch of the injection faces potential threats, including the Trump administration’s proposed cuts to federal funding ...

The injectable HIV prevention treatment Yetzugo, made by Gilead Sciences, has received FDA approval, offering a twice-yearly ...

There is still no cure or effective vaccine for HIV, but scientists have opened up new possibilities in HIV treatment and ...